Core Insights - Shenzhen's biopharmaceutical and medical device industry is rapidly developing, aiming to create a globally influential industrial ecosystem [1] - The projected output value for Shenzhen's pharmaceutical industry in 2024 is 54.783 billion, while the medical device industry is expected to reach approximately 103 billion [1] - The city plans to enhance the integration of industry, academia, research, medicine, and finance to support the development of high-quality projects [1] Industry Development - The "Starry Shenzhen" 20+8 industry salon focused on the pharmaceutical and medical device sectors, attended by nearly 140 representatives from various sectors [1][2] - A report on the innovation and development trends of Shenzhen's biopharmaceutical and medical device industry was presented, alongside investment data insights [2] - The event included discussions on the development trends of Shenzhen's medical industry and global investment trends, featuring experts from leading companies and investment institutions [2] Government Initiatives - In April, the Shenzhen Development and Reform Commission released measures to support the development of the pharmaceutical and medical device sectors, focusing on nine key areas with 32 specific measures [1] - The Fuyuan District is enhancing the competitiveness of the biopharmaceutical sector through financial resource integration and a collaborative mechanism between government and market operations [2] Future Plans - Shenzhen Stock Exchange Association plans to continue hosting the 20+8 industry salon series to support high-quality development of new productive forces in Shenzhen [3]